In a report released today, Stephanie Wissink from Jefferies maintained a Buy rating on Beauty Health (SKIN – Research Report), with a price target of $24.00. The company’s shares closed last Tuesday at $11.78, close to its 52-week low of $9.95.
According to TipRanks.com, Wissink is a 1-star analyst with an average return of -2.2% and a 41.6% success rate. Wissink covers the Consumer Goods sector, focusing on stocks such as Petco Health and Wellness Company, Bj’s Wholesale Club Holdings, and The Estée Lauder Companies.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Beauty Health with a $23.14 average price target.
Based on Beauty Health’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $75.42 million and net profit of $32.51 million. In comparison, last year the company earned revenue of $47.54 million and had a GAAP net loss of $3.27 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Vesper Healthcare Acquisition Corp is a blank check company.
Read More on SKIN: